These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 11229767)

  • 1. Structure-activity relationships of quinazoline derivatives: dual-acting compounds with inhibitory activities toward both TNF-alpha production and T cell proliferation.
    Tobe M; Isobe Y; Tomizawa H; Matsumoto M; Obara F; Nagasaki T; Hayashi H
    Bioorg Med Chem Lett; 2001 Feb; 11(4):545-8. PubMed ID: 11229767
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Structure-activity relationships of 6-nitroquinazolines: dual-acting compounds with inhibitory activities toward both TNF-alpha production and T cell proliferation.
    Tobe M; Isobe Y; Tomizawa H; Nagasaki T; Obara F; Matsumoto M; Hayashi H
    Chem Pharm Bull (Tokyo); 2002 Aug; 50(8):1073-80. PubMed ID: 12192139
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Structure-activity relationships of 6-fluoroquinazolines: dual-acting compounds with inhibitory activities toward both TNF-alpha production and T cell proliferation.
    Tobe M; Isobe Y; Tomizawa H; Nagasaki T; Obara F; Hayashi H
    Bioorg Med Chem; 2003 Feb; 11(4):609-16. PubMed ID: 12538026
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synthesis and evaluation of 6-nitro-7-(1-piperazino)quinazolines: dual-acting compounds with inhibitory activities toward both tumor necrosis factor-alpha (TNF-alpha) production and T cell proliferation.
    Tobe M; Isobe Y; Tomizawa H; Nagasaki T; Aoki M; Negishi T; Hayashi H
    Chem Pharm Bull (Tokyo); 2003 Sep; 51(9):1109-12. PubMed ID: 12951460
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Studies on disease-modifying antirheumatic drugs: synthesis of novel quinoline and quinazoline derivatives and their anti-inflammatory effect.
    Baba A; Kawamura N; Makino H; Ohta Y; Taketomi S; Sohda T
    J Med Chem; 1996 Dec; 39(26):5176-82. PubMed ID: 8978845
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Design, synthesis, and evaluation of quinazoline T cell proliferation inhibitors.
    Sagiv-Barfi I; Weiss E; Levitzki A
    Bioorg Med Chem; 2010 Sep; 18(17):6404-13. PubMed ID: 20674367
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Novel inhibitor of p38 MAP kinase as an anti-TNF-alpha drug: discovery of N-[4-[2-ethyl-4-(3-methylphenyl)-1,3-thiazol-5-yl]-2-pyridyl]benzamide (TAK-715) as a potent and orally active anti-rheumatoid arthritis agent.
    Miwatashi S; Arikawa Y; Kotani E; Miyamoto M; Naruo K; Kimura H; Tanaka T; Asahi S; Ohkawa S
    J Med Chem; 2005 Sep; 48(19):5966-79. PubMed ID: 16162000
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Synthesis and antitumor activity of novel quinazoline derivatives containing thiosemicarbazide moiety.
    He J; Wang X; Zhao X; Liang Y; He H; Fu L
    Eur J Med Chem; 2012 Aug; 54():925-30. PubMed ID: 22749192
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Molecular modeling, enzyme activity, anti-inflammatory and antiarthritic activities of newly synthesized quinazoline derivatives.
    Abuelizz HA; Hassane AE; Marzouk M; Ezzeldin E; Ali AA; Al-Salahi R
    Future Med Chem; 2017 Nov; 9(17):1995-2009. PubMed ID: 28789563
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ultrasound-promoted synthesis and immunosuppressive activity of novel quinazoline derivatives.
    Zhang L; Gao Z; Peng C; Bin ZY; Zhao D; Wu J; Xu Q; Li JX
    Mol Divers; 2012 Aug; 16(3):579-90. PubMed ID: 22890961
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Methotrexate analogues display enhanced inhibition of TNF-α production in whole blood from RA patients.
    van der Heijden JW; Assaraf YG; Gerards AH; Oerlemans R; Lems WF; Scheper RJ; Dijkmans BA; Jansen G
    Scand J Rheumatol; 2014; 43(1):9-16. PubMed ID: 23987246
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Biological evaluation of novel 6-Arylbenzimidazo[1,2-c]quinazoline derivatives as inhibitors of LPS-induced TNF-alpha secretion.
    Galarce GD; Foncea RE; Edwards AM; Pessoa-Mahana H; Pessoa-Mahana CD; Ebensperger RA
    Biol Res; 2008; 41(1):43-50. PubMed ID: 18769762
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A new three-component reaction: green synthesis of novel isoindolo[2,1-a]quinazoline derivatives as potent inhibitors of TNF-α.
    Kumar KS; Kumar PM; Kumar KA; Sreenivasulu M; Jafar AA; Rambabu D; Krishna GR; Reddy CM; Kapavarapu R; Shivakumar K; Priya KK; Parsa KV; Pal M
    Chem Commun (Camb); 2011 May; 47(17):5010-2. PubMed ID: 21445417
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Studies on quinazolines. 5. 2,3-dihydroimidazo[1,2-c]quinazoline derivatives: a novel class of potent and selective alpha 1-adrenoceptor antagonists and antihypertensive agents.
    Chern JW; Tao PL; Yen MH; Lu GY; Shiau CY; Lai YJ; Chien SL; Chan CH
    J Med Chem; 1993 Jul; 36(15):2196-207. PubMed ID: 8101878
    [TBL] [Abstract][Full Text] [Related]  

  • 15. New gamma-fluoromethotrexates modified in the pteridine ring: synthesis and in vitro immunosuppressive activity.
    Kokuryo Y; Nakatani T; Kakinuma M; Kabaki M; Kawata K; Kugimiya A; Kawada K; Matsumoto M; Suzuki R; Ohtani M
    Eur J Med Chem; 2000 May; 35(5):529-34. PubMed ID: 10889331
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Substituted isoquinolines and quinazolines as potential antiinflammatory agents. Synthesis and biological evaluation of inhibitors of tumor necrosis factor alpha.
    Chao Q; Deng L; Shih H; Leoni LM; Genini D; Carson DA; Cottam HB
    J Med Chem; 1999 Sep; 42(19):3860-73. PubMed ID: 10508435
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of the kinase inhibitor CGP41251 (PKC 412) on lymphocyte activation and TNF-alpha production.
    Si MS; Reitz BA; Borie DC
    Int Immunopharmacol; 2005 Jul; 5(7-8):1141-9. PubMed ID: 15914319
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Discovery of aminoquinazolines as potent, orally bioavailable inhibitors of Lck: synthesis, SAR, and in vivo anti-inflammatory activity.
    DiMauro EF; Newcomb J; Nunes JJ; Bemis JE; Boucher C; Buchanan JL; Buckner WH; Cee VJ; Chai L; Deak HL; Epstein LF; Faust T; Gallant P; Geuns-Meyer SD; Gore A; Gu Y; Henkle B; Hodous BL; Hsieh F; Huang X; Kim JL; Lee JH; Martin MW; Masse CE; McGowan DC; Metz D; Mohn D; Morgenstern KA; Oliveira-dos-Santos A; Patel VF; Powers D; Rose PE; Schneider S; Tomlinson SA; Tudor YY; Turci SM; Welcher AA; White RD; Zhao H; Zhu L; Zhu X
    J Med Chem; 2006 Sep; 49(19):5671-86. PubMed ID: 16970394
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Investigation of quinazolines as inhibitors of breast cancer resistance protein (ABCG2).
    Juvale K; Gallus J; Wiese M
    Bioorg Med Chem; 2013 Dec; 21(24):7858-73. PubMed ID: 24184213
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Synthesis and antitumor activity evaluation of quinazoline derivatives bearing piperazine-1-carbodithioate moiety at C4-position.
    Zhang Y; Yang CR; Tang X; Cao SL; Ren TT; Gao M; Liao J; Xu X
    Bioorg Med Chem Lett; 2016 Oct; 26(19):4666-4670. PubMed ID: 27575478
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.